# CureGBM

> CureGBM is a clinical-stage MedTech company advancing Sonodynamic Therapy (SDT) for the treatment of brain tumours.

CureGBM focuses on developing and supporting a European pathway for Sonodynamic Therapy as an innovative treatment approach for patients with brain tumours, including glioblastoma.

## Key Information

- [Home](https://www.curegbm.co.uk/)
- [Patients](https://www.curegbm.co.uk/patients/)
- [Healthcare Professionals](https://www.curegbm.co.uk/healthcare-professionals/)
- [Clinical SDT Trials](https://www.curegbm.co.uk/clinical-sdt-trials/)
- [About CureGBM](https://www.curegbm.co.uk/about-us/)
- [Contact](https://www.curegbm.co.uk/contact/)

## About CureGBM

CureGBM is focused on advancing Sonodynamic Therapy for brain tumours and supporting the development of new treatment options for people affected by glioblastoma.

## Sonodynamic Therapy

Sonodynamic Therapy combines a sonosensitising agent with focused ultrasound and is being investigated as a potential approach to treating brain tumours.

## Patients and Healthcare Professionals

The CureGBM website provides information for patients, families and healthcare professionals about Sonodynamic Therapy, clinical developments and CureGBM's work.

## Medical Information

Information published by CureGBM is provided for informational purposes and does not replace individual medical advice, diagnosis or treatment from a qualified healthcare professional.

## Official Source

For current and authoritative information about CureGBM, its activities and clinical developments, refer to the official website:

https://www.curegbm.co.uk/